Article Information
History
- November 15, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Nick Andrews, PhD*,1,2,
- Julia Stowe, PhD*,1,2,
- Freja Kirsebom, PhD1,
- Charlotte Gower, DPhil1,
- Mary Ramsay, MBBS, FFPH1,2 and
- Jamie Lopez Bernal, PhD, MBBS1,2,3,#
- 1UK Health Security Agency, London, UK
- 2NIHR Health Protection Research Unit in Vaccines and Immunisation, London School of Hygiene and Tropical Medicine, London, UK
- 3NIHR Health Protection Research Unit in Respiratory Infections, Imperial College London, London, UK
- ↵#Corresponding author; email: jamie.lopezbernal2{at}phe.gov.uk
Posted November 15, 2021.
Effectiveness of BNT162b2 (Comirnaty, Pfizer-BioNTech) COVID-19 booster vaccine against covid-19 related symptoms in England: test negative case-control study
